Does ENTRECTINIB Cause Pleural effusion? 26 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 26 reports of Pleural effusion have been filed in association with ENTRECTINIB (Rozlytrek). This represents 1.7% of all adverse event reports for ENTRECTINIB.
26
Reports of Pleural effusion with ENTRECTINIB
1.7%
of all ENTRECTINIB reports
5
Deaths
8
Hospitalizations
How Dangerous Is Pleural effusion From ENTRECTINIB?
Of the 26 reports, 5 (19.2%) resulted in death, 8 (30.8%) required hospitalization, and 2 (7.7%) were considered life-threatening.
Is Pleural effusion Listed in the Official Label?
Yes, Pleural effusion is listed as a known adverse reaction in the official FDA drug label for ENTRECTINIB.
What Other Side Effects Does ENTRECTINIB Cause?
Dizziness (143)
Off label use (137)
Death (126)
Disease progression (105)
Taste disorder (68)
No adverse event (65)
Constipation (60)
Fatigue (60)
Drug ineffective (58)
Blood creatinine increased (57)
What Other Drugs Cause Pleural effusion?
DASATINIB (2,424)
METHOTREXATE (1,310)
CYCLOPHOSPHAMIDE (1,239)
IBRUTINIB (1,205)
RITUXIMAB (1,168)
PREDNISONE (1,144)
NIVOLUMAB (1,061)
ADALIMUMAB (1,036)
DEXAMETHASONE (879)
PACLITAXEL (862)
Which ENTRECTINIB Alternatives Have Lower Pleural effusion Risk?
ENTRECTINIB vs ENZALUTAMIDE
ENTRECTINIB vs EPCORITAMAB
ENTRECTINIB vs EPCORITAMAB-BYSP
ENTRECTINIB vs EPERISONE
ENTRECTINIB vs EPHEDRINE